LOGIN  |  REGISTER
Amneal Pharmaceuticals

LifeWallet to Report Fourth Quarter and Full Year 2022 Results on Friday, March 31, 2023

March 20, 2023 | Last Trade: US$0.95 0.04 -4.01

CORAL GABLES, Fla., March 20, 2023 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. d/b/a LifeWallet (NASDAQ: LIFW) (“LifeWallet”, or “LIFW” or “the Company”), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced that the Company will release its fourth quarter and full year 2022 financial results after the market closes on Friday, March 31, 2023.

LifeWallet will host a conference call and live webcast to review the Company’s fourth quarter and full year results for investors and analysts at 4:30 p.m. Eastern Time on Friday, March 31, 2023. To access this call, we encourage you to pre-register using this link: LifeWallet Q4 2022 Earnings Pre Registration.

A live webcast of the conference call will be accessible from the Investors section of LifeWallet’s website at https://www.lifewallet.com.

A replay of the webcast will be archived and accessible at investor.lifewallet.com.

About LifeWallet

Founded in 2014 as MSP Recovery, LifeWallet has become a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader, disrupting the antiquated healthcare reimbursement system with data-driven solutions to secure recoveries from responsible parties. LifeWallet provides comprehensive solutions for multiple industries including healthcare, legal, education, and sports NIL, while innovating technologies to help save lives. For more information, visit: lifewallet.com.

For Investors:
ICR, Inc.
Marc Griffin
This email address is being protected from spambots. You need JavaScript enabled to view it.

For Media:
ICR, Inc.
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page